Truepill has reduced its global workforce by 14 percent in another round of job cuts for the digital pharmacy, a spokesperson told Becker's.

Rite Aid will team up with WellSpan Health, an eight-hospital system with locations scattered across Pennsylvania and Maryland, to weave the two organizations' priorities together and improve health outcomes of patients.

Pfizer Chairman and CEO Albert Bourla, PhD, has tested positive for COVID-19, the executive said in an Aug. 15 statement on the company's website. 

Cambridge, Mass.-based healthcare investment fund Gurnet Point Capital and Menlo Park Calif.-based healthcare investment firm Patient Square Capital completed their acquisition of biopharmaceutical company Radius Health, the company said Aug. 15.

Save Mart, a grocery store chain concentrated in California and Nevada, plans to shutter its 89 pharmacies and move its services to Walgreens Aug. 16, according to the Reno Gazette Journal and the Union Democrat. 

Health experts are questioning the length of Pfizer's antiviral treatment, as COVID-19 rebounds seem to exceed "rare" status, according to Time. 

The FDA approved the biotechnology company Genentech's Xofluza drug to treat children aged 5-12 with influenza.

The Institute for Safe Medication Practices published a guideline for drugs used during procedures, the first document of its kind, Aug. 11.  

Novartis, a Switzerland-based pharmaceutical company, confirmed a report of two children dying from liver complications six weeks after taking its gene therapy drug, Zolgensma, Bloomberg reported Aug. 11. 

Billings (Mont.) Clinic has expanded its partnership with Stoughton, Mass.-based Shields to provide enhanced specialty pharmacy services, according to an Aug. 11 press release.

Retail pharmacy company Walgreens is offering bonuses up to $75,000 to recruit pharmacists amid a workforce shortage, The Wall Street Journal reported Aug. 11. 

More than three-fourths of community pharmacies are struggling with staff shortages, according to a survey released Aug. 11 by the National Community Pharmacists Association. 

When the FDA allowed any state-licensed pharmacist to prescribe a COVID-19 antiviral to patients in July, some health organizations criticized the decision while others cheered, but pharmacies aren't picking up the slack, NBC reported Aug. 10. 

The White House is working with multiple companies to bottle monkeypox vaccines, but the earliest estimates put the distribution at late 2022 to early 2023, two senior Biden administration officials and two other sources familiar with the matter told Politico. 

As workforce shortages plague pharmacies and the industry adjusts to the $739 billion drug-pricing bill the Senate narrowly passed Aug. 7, here are what five pharmacy hospital and health system executives told Becker's their priorities are for the rest of 2022.

The U.S. is now allowing fractional doses of the Jynneos monkeypox vaccine to be administered via an injection that delivers the dose between, rather than under, layers of skin — an effort that will stretch low vaccine supplies, according to federal health officials. 

The following 10 hospitals, health systems and hospital operators have posted job listings seeking pharmacy leaders in the last week.

Some patients can now skip the pharmacy line and pick up their prescriptions at kiosks in two physicians' offices, thanks to AdventHealth, an Altamonte Springs, Fla.-based system with about 50 hospitals.

The FDA said Aug. 9 tests of samples of a Merck diabetes drug detected substances that can cause cancer, and to avoid shortages, the department said it would allow increased levels of the carcinogen by nearly 150 percent. 

Cambridge, Mass.-based biotechnology company Biogen is cutting office space and planning layoffs after its Alzheimer's drug Aduhelm proved unpopular with providers and insurers, the Boston Globe reported Aug. 9.